Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02450006

Intermountain INSPIRE Registry

INtermountain Healthcare Biological Samples Collection Project and Investigational REgistry for the On-going Study of Disease Origin, Progression and Treatment (Intermountain INSPIRE Registry)

Status
Recruiting
Phase
Study type
Observational
Enrollment
50,000 (estimated)
Sponsor
Intermountain Health Care, Inc. · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

To collect biological samples, clinical information and laboratory data from patients diagnosed with any healthcare-related conditions who are seen at facilities affiliated with Intermountain Healthcare, including patients and their family members, and to collect the same information and samples from a general population including disease-free subjects.

Detailed description

This is an observational, non-randomized, open, long-term project to collect a variety of biological samples, in addition to usual or specialized care clinical information and laboratory test results, from patients who present to Intermountain Healthcare-affiliated facilities, with symptoms of any healthcare-related conditions, as well as from a general population including disease-free subjects. The INSPIRE Registry will include all subjects enrolled in the HHD registry (IRB # 1007406, approval date 01- 16-2009) and the cathlab database registry (IRB # 1008366, approval date 10/04/2000), as of IRB approval date of this INSPIRE amended protocol. Since this is a registry database project, there are no investigational treatments, drugs or procedures associated with participation. Information obtained from this registry project will not have direct or immediate benefit for any of the participants. Biological samples and subject information will be obtained during diagnostic procedures and/or treatment that are generally part of usual or specialized care for the underlying healthcare-related condition. Sample testing and registry data utilization for various research projects can be initiated only after the appropriate approval is obtained from a registry oversight/management committee, and when appropriate, the Institutional Review Board. After informed consent is obtained from the patient, the biological samples will be obtained in one of the following ways: 1. During a procedure from access lines inserted for the procedure, or 2. When other ordered lab work is done, or 3. As a separate sample collection if no other lab work is planned. Biological sample collection from the general population may be a separate blood draw and/or sample collection. Participating patients may be asked to provide one or more collections of biological samples. Biological samples may be used in current and future research tests multiple times, or until the sample is consumed. In addition, participating subjects may be asked to complete the IRBreviewed questionnaires.

Conditions

Timeline

Start date
2015-04-01
Primary completion
2050-04-01
Completion
2050-04-01
First posted
2015-05-21
Last updated
2026-04-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02450006. Inclusion in this directory is not an endorsement.